Abstract
A 45-yr-old female presented with a rapidly enlarging bony tumor that was eventually identified as a Philadelphia chromosome (Ph1)-positive myeloproliferative disorder with extramedullary blastic transformation. This transformation occurred in the absence of demonstrable chronic or acute leukemic phase. She had no history of a chronic or prodromal illness in spite of a bone marrow biopsy showing myelofibrosis and liver biopsy documenting extramedullary hematopoiesis. This case represents a unique constellation of features of the myeloproliferative syndrome in which the diagnosis was obscure until special stains of the bony tumor and cytogenetic studies were performed.
| Original language | English |
|---|---|
| Pages (from-to) | 793-801 |
| Number of pages | 9 |
| Journal | Blood |
| Volume | 52 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Dec 1 1978 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Hematology
Fingerprint
Dive into the research topics of 'Myeloproliferative syndromes: A unique presentation of chronic myelogenous leukemia (CML) as a primary tumor of bone'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS